Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDECABTAGENE VICLEUCEL vs IDELALISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDECABTAGENE VICLEUCEL vs IDELALISIB: Safety Overview

Metric IDECABTAGENE VICLEUCEL IDELALISIB
Total FAERS Reports 1,037 6,862
Deaths Reported 137 1,548
Death Rate 13.2% 22.6%
Hospitalizations 356 2,962
Average Patient Age 65.3 yrs 70.0 yrs
% Female Patients 41.9% 38.4%
FDA Approval Date N/A Jul 23, 2014
Manufacturer Celgene Corporation Gilead Sciences, Inc.
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription